These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6549572)

  • 1. Intrathecally administered m-AMSA in the rhesus monkey.
    Gormley P; Riccardi R; O'Neill D; Poplack D
    Cancer Drug Deliv; 1984; 1(2):101-7. PubMed ID: 6549572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM; Schneider RJ; Young CW
    Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia.
    Kahn SB; Sklaroff R; Lebedda J; Conroy JF; Bulova S; Brodsky I
    Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA, NSC 249992) on human tumors in nude mice.
    Sordillo PP; Helson L; Lesser M
    Cancer Clin Trials; 1980; 3(4):385-9. PubMed ID: 6893575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
    Valdivieso M; Stroehlein JR; Bedikian AY; Karlin DA; Legha SS; Bennetts RW; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).
    Von Hoff DD; Elson D; Polk G; Coltman C
    Cancer Treat Rep; 1980; 64(2-3):356-8. PubMed ID: 6931630
    [No Abstract]   [Full Text] [Related]  

  • 7. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia.
    Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ
    Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid-chromatographic method for the determination of 4'-(9-acridinylamino)methanesulfon-m-anisidide in plasma.
    Jurlina JL; Paxton JW
    J Chromatogr; 1983 Sep; 276(2):367-74. PubMed ID: 6688811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC; Zwelling LA; Gormley P; Young RC
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor penetration of AMSA in man.
    Guo ZG; Savaraj N; Feun LG; Lu K; Stewart DJ; Luna M; Benjamin RS; Loo TL
    Cancer Invest; 1983; 1(6):475-8. PubMed ID: 6689404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
    Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).
    Stewart DJ; Zhengang G; Lu K; Savaraj N; Feun LG; Luna M; Benjamin RS; Keating MJ; Loo TL
    Cancer Chemother Pharmacol; 1984; 12(2):116-9. PubMed ID: 6583026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of refractory acute myeloblastic leukemia who achieved complete remission by a new anti-leukemic agent, 4'-(9-acridinylamino) methanesulfon-m-anisidide (AMSA)].
    Nagura E; Kawashima K; Suzuki H; Ohno R; Yamada K; Yokomaku S; Ogawa M
    Rinsho Ketsueki; 1983 May; 24(5):632-8. PubMed ID: 6577212
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).
    Arlin ZA; Fanucchi MP; Gee TS; Kempin SJ; Mertelsmann R; Young CW; Clarkson BD
    Blood; 1982 Nov; 60(5):1224-6. PubMed ID: 6957250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M; Andersson BS; McCredie KB; Beran M
    Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma.
    Dombernowsky P; Siegenthaler P; Somers R; Hansen HH
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):71-4. PubMed ID: 6896306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE; Howard J; Wittes R
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng E; Currie VE
    Am J Clin Oncol; 1983 Aug; 6(4):459-62. PubMed ID: 6688151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.